Delivery Order SPE2DB22D1017-SPE2DB25FE7LY
Award Date
10/18/24
Potential Completion Date
10/21/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,785.56 firm fixed-price delivery order is for the supply of 4,567,100,884 units of Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,151.67 firm fixed-price delivery order covers the supply of 4,566,994,648 units of the drug Ondansetron HCL 4 mg tablets in 30-count packages. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,919.65 firm fixed-price delivery order contract is for the supply of Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,595.07 firm fixed-price delivery order is for the supply of 4,566,629,069 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,908.81 firm fixed-price delivery order is for the supply of 4,566,161,827 tablets of the medication Ondansetron HCL 4 mg. The contract has an ultimate completion date of October 22, 2024 and was awarded on October 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $7,873.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,566,340,622 units of Ondansetron HCL 4 mg tablets, with a firm fixed price and an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,682.47 firm fixed-price delivery order is for the supply of 4,564,603,975 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of May 15, 2024 and was awarded on May 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,158.50 firm fixed-price delivery order is for the supply of 4,560,090,259 units of Ondansetron HCL 4 mg tablets with an ultimate completion date of March 1, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $8,762.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4,566,705,223 units of Ondansetron HCl 8 mg tablets. The contract has an ultimate completion date of December 13, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,400.57 firm fixed-price delivery order is for the supply of 4,559,623,831 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of January 18, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...